Biotechnology may be the defining strategic asset of the 21st century—if we choose to invest. At a Capitol Hill event hosted by the Hoover Institution and Stanford School of Engineering to launch the 2025 Stanford Emerging Technology Review (SETR), Hoover fellows Herb Lin and Amy Zegart explored how biotechnology could transform global supply chains—and why the U.S. must act now. Watch the full panel discussion at the “related video” above.
#Biology #SyntheticBiology #Biotechnology #AI #ArtificialIntelligence #EmergingTechnology #SETR #ChatGPT #OpenAI #JensenHuang #Semiconductor #Technology #Tech #Innovation #GraphicsCard #China #Taiwan #USA #US #UnitedStates #America #NationalSecurity #Politics #Geopolitics #Economics #Policy #Market #SiliconValley #Investing #DonaldTrump #Trump #XiJinPing #YouTube #YouTubeShorts #YouTubeShort #Shorts #Short #ShortsVideo #ShortVideo #HooverInstitution #CondoleezzaRice #AmyZegart #HerbLin